title: Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations.
abstract: Dietary flavanols and flavonols, flavonoid subclasses, have been recently associated with a lower risk of type 2 diabetes (T2D) in Europe. Even within the same subclass, flavonoids may differ considerably in bioavailability and bioactivity. We aimed to examine the association between individual flavanol and flavonol intakes and risk of developing T2D across European countries. The European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study was conducted in 8 European countries across 26 study centers with 340,234 participants contributing 3.99 million person-years of follow-up, among whom 12,403 incident T2D cases were ascertained and a center-stratified subcohort of 16,154 individuals was defined. We estimated flavonoid intake at baseline from validated dietary questionnaires using a database developed from Phenol-Explorer and USDA databases. We used country-specific Prentice-weighted Cox regression models and random-effects meta-analysis methods to estimate HRs. Among the flavanol subclass, we observed significant inverse trends between intakes of all individual flavan-3-ol monomers and risk of T2D in multivariable models (all P-trend < 0.05). We also observed significant trends for the intakes of proanthocyanidin dimers (HR for the highest vs. the lowest quintile: 0.81; 95% CI: 0.71, 0.92; P-trend = 0.003) and trimers (HR: 0.91; 95% CI: 0.80, 1.04; P-trend = 0.07) but not for proanthocyanidins with a greater polymerization degree. Among the flavonol subclass, myricetin (HR: 0.77; 95% CI: 0.64, 0.93; P-trend = 0.001) was associated with a lower incidence of T2D. This large and heterogeneous European study showed inverse associations between all individual flavan-3-ol monomers, proanthocyanidins with a low polymerization degree, and the flavonol myricetin and incident T2D. These results suggest that individual flavonoids have different roles in the etiology of T2D.
authors.affiliation: MRC Epidemiology Unit, University of Cambridge, Institute of Metabolic Science, Cambridge, UK.
authors.forename: Raul
authors.initials: R
authors.lastname: Zamora-Ros
authors.forename: Nita G
authors.initials: NG
authors.lastname: Forouhi
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Sharp
authors.forename: Carlos A
authors.initials: CA
authors.lastname: González
authors.forename: Brian
authors.initials: B
authors.lastname: Buijsse
authors.forename: Marcela
authors.initials: M
authors.lastname: Guevara
authors.forename: Yvonne T
authors.initials: YT
authors.lastname: van der Schouw
authors.forename: Pilar
authors.initials: P
authors.lastname: Amiano
authors.forename: Heiner
authors.initials: H
authors.lastname: Boeing
authors.forename: Lea
authors.initials: L
authors.lastname: Bredsdorff
authors.forename: Guy
authors.initials: G
authors.lastname: Fagherazzi
authors.forename: Edith J
authors.initials: EJ
authors.lastname: Feskens
authors.forename: Paul W
authors.initials: PW
authors.lastname: Franks
authors.forename: Sara
authors.initials: S
authors.lastname: Grioni
authors.forename: Verena
authors.initials: V
authors.lastname: Katzke
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Key
authors.forename: Kay-Tee
authors.initials: KT
authors.lastname: Khaw
authors.forename: Tilman
authors.initials: T
authors.lastname: Kühn
authors.forename: Giovanna
authors.initials: G
authors.lastname: Masala
authors.forename: Amalia
authors.initials: A
authors.lastname: Mattiello
authors.forename: Esther
authors.initials: E
authors.lastname: Molina-Montes
authors.forename: Peter M
authors.initials: PM
authors.lastname: Nilsson
authors.forename: Kim
authors.initials: K
authors.lastname: Overvad
authors.forename: Florence
authors.initials: F
authors.lastname: Perquier
authors.forename: M Luisa
authors.initials: ML
authors.lastname: Redondo
authors.forename: Fulvio
authors.initials: F
authors.lastname: Ricceri
authors.forename: Olov
authors.initials: O
authors.lastname: Rolandsson
authors.forename: Isabelle
authors.initials: I
authors.lastname: Romieu
authors.forename: Nina
authors.initials: N
authors.lastname: Roswall
authors.forename: Augustin
authors.initials: A
authors.lastname: Scalbert
authors.forename: Matthias
authors.initials: M
authors.lastname: Schulze
authors.forename: Nadia
authors.initials: N
authors.lastname: Slimani
authors.forename: Annemieke M W
authors.initials: AM
authors.lastname: Spijkerman
authors.forename: Anne
authors.initials: A
authors.lastname: Tjonneland
authors.forename: Maria Jose
authors.initials: MJ
authors.lastname: Tormo
authors.forename: Marina
authors.initials: M
authors.lastname: Touillaud
authors.forename: Rosario
authors.initials: R
authors.lastname: Tumino
authors.forename: Daphne L
authors.initials: DL
authors.lastname: van der A
authors.forename: Geertruida J
authors.initials: GJ
authors.lastname: van Woudenbergh
authors.forename: Claudia
authors.initials: C
authors.lastname: Langenberg
authors.forename: Elio
authors.initials: E
authors.lastname: Riboli
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Wareham
mesh_terms: D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology*; D004032:Diet; D005060:Europe; D005260:Female; D005419:Flavonoids / Q000008:administration & dosage; D044948:Flavonols / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008019:Life Style; D008297:Male; D008875:Middle Aged; D009043:Motor Activity; D015999:Multivariate Analysis; D009752:Nutritional Status; D044945:Proanthocyanidins / Q000008:administration & dosage; D016016:Proportional Hazards Models; D011446:Prospective Studies; D012307:Risk Factors; D012959:Socioeconomic Factors; D011795:Surveys and Questionnaires; D044465:White People
chemical_list: D005419:Flavonoids; D044948:Flavonols; D044945:Proanthocyanidins; C013221:proanthocyanidin; C404987:flavan-3-ol; C040015:myricetin